N
TENX icon

Nuveen’s Tenax Therapeutics TENX Stock Holding History

Nuveen’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35M Buy
+161,187
New +$2.06M ﹤0.01% 2497

Other funds holding TENX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Nuveen's TENX Position: Q2 2026 in Review

Nuveen opened a new position in Tenax Therapeutics (TENX) in Q2 2026: 161,187 shares worth $2.35M. The stake represents ﹤0.01% of the portfolio and ranks #2497 among its holdings.

30 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Nuveen held 161,187 shares of Tenax Therapeutics worth $2.35M as of Q2 2026.
  • Tenax Therapeutics was a new Nuveen position in Q2 2026.
  • Tenax Therapeutics made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2497 holding.
  • 30 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.